Skip to content
PulseHub

The Zimbabwean Government Rejects ‘Unbalanced’ US Healthcare Assistance Deal Over Data Fears

Health funding image
The proposed American funding would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has turned down a significant American health deal valued at $367m (272 million pounds) spanning five years because of the United States' request for confidential data.

The decision was revealed following a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "skewed".

An official representative has since clarified that the United States was demanding access to health data for scientific study and commercial gain while was not willing to guarantee the benefits from any future vaccines.

"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged continued negotiations to reach a agreement acceptable to both sides so the country's critical HIV programme can continue.

Wider Background

Zimbabwe's decision comes after a similar situation in Kenya, where a court blocked a related health funding agreement after legal challenges were filed about the security of Kenyans' medical information.

After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

USAID had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.

According to reports, Sixteen African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.

Specifics of the Declined Agreement

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through US-supported programmes," Tremont said.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that provided information," Mangwana explained.

"Effectively, our nation would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our people should a future disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks previously set up via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.

"This framework is designed to ensure that when a country contributes its data, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."

The government's concerns over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We are open to continued dialogue with our American counterparts on how subsequent co-operation might be structured in a way that honours the independence and dignity of both nations."

Medical Community Reaction

Medical experts said it understood the government's concerns, but recommended that talks should continue since a large portion of the nation's Aids initiatives relied on external financing.

"Where specific concerns exist, including those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," the group commented.

The halted deal highlights the ongoing challenges between accepting crucial foreign assistance and safeguarding a country's data in an ever more interconnected world.

About the author

Linda Delacruz

Maya Chen is a tech journalist and business analyst with over a decade of experience covering digital transformation and startup ecosystems across North America.

PulseHub

Type to search articles.